Position in TARS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,530,826
-$179,010 QoQ
Shares Held
24,322
-0.2% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#113
of 256 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $48,509,639 across 38 Biotechnology names. TARS ranks #6 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,347 | $22,525,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,647 | $7,262,370 | |
| 3 | INCY |
Incyte Corp
|
18,327 | $2,077,548 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
51,212 | $1,908,671 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
8,476 | $1,587,385 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
This page
|
24,322 | $1,530,826 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,158 | $1,410,609 | |
| 8 | MRNA |
Moderna, Inc.
|
16,522 | $1,157,035 |
All Filings in TARS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,530,826 | 24,322 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,709,836 | 24,374 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||